UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study

Clinical pharmacology and therapeutics, 2009-01, Vol.85 (1), p.31-35

2009

Volltextzugriff (PDF)

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial

Neurology, 2005-07, Vol.65 (2), p.286-292

2005

Volltextzugriff (PDF)

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

Clinical genetics, 2004-04, Vol.65 (4), p.267-277

2004

Volltextzugriff (PDF)

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations

Clinical genetics, 2007-04, Vol.71 (4), p.311-319

2007

Volltextzugriff (PDF)

Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease

American journal of human genetics, 2019-06, Vol.104 (6), p.1116-1126

2019

Volltextzugriff (PDF)

Human Mendelian pain disorders: a key to discovery and validation of novel analgesics

Clinical genetics, 2012-10, Vol.82 (4), p.367-373

2012

Volltextzugriff (PDF)

Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial

Neurology, 1999-09, Vol.53 (5), p.1000-1000

1999

Volltextzugriff (PDF)

Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease

Science translational medicine, 2018-10, Vol.10 (461)

2018

Volltextzugriff (PDF)

What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration

Clinical genetics, 2012-04, Vol.81 (4), p.325-333

2012

Volltextzugriff (PDF)

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

Nature medicine, 2009-12, Vol.15 (12), p.1407-1413

2009

Volltextzugriff (PDF)

Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results

Clinical genetics, 2014-04, Vol.85 (4), p.303-311

2014

Volltextzugriff (PDF)

Deranged neuronal calcium signaling and Huntington disease

Biochemical and biophysical research communications, 2004-10, Vol.322 (4), p.1310-1317

2004

Volltextzugriff (PDF)

The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models

Neurotherapeutics, 2021-04, Vol.18 (2), p.1017-1038

2021

Volltextzugriff (PDF)

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

Clinical pharmacology and therapeutics, 2013-08, Vol.94 (2), p.243-251

2013

Volltextzugriff (PDF)

Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma

Scientific reports, 2021-11, Vol.11 (1), p.21975-16, Article 21975

2021

Volltextzugriff (PDF)

A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease

Nature neuroscience, 2015-06, Vol.18 (6), p.807-816

2015

Volltextzugriff (PDF)

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

Nature genetics, 2003-09, Vol.35 (1), p.76-83

2003

Volltextzugriff (PDF)

Personalized gene silencing therapeutics for Huntington disease

Clinical genetics, 2014-07, Vol.86 (1), p.29-36

2014

Volltextzugriff (PDF)

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Nature neuroscience, 2002-08, Vol.5 (8), p.731-736

2002

Volltextzugriff (PDF)

Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis

Nature genetics, 2004-01, Vol.36 (1), p.77-82

2004

Volltextzugriff (PDF)

The emerging era of pharmacogenomics: current successes, future potential, and challenges

Clinical genetics, 2014-07, Vol.86 (1), p.21-28

2014

Volltextzugriff (PDF)

Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

Science (American Association for the Advancement of Science), 2001-07, Vol.293 (5529), p.493-498

2001

Volltextzugriff (PDF)

Intestinal ABCA1 directly contributes to HDL biogenesis in vivo

The Journal of clinical investigation, 2006-04, Vol.116 (4), p.1052-1062

2006

Volltextzugriff (PDF)

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

The Journal of clinical investigation, 2005-05, Vol.115 (5), p.1333-1342

2005

Volltextzugriff (PDF)

A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

Clinical genetics, 1999-06, Vol.55 (6), p.450-454

1999

Volltextzugriff (PDF)

1 – 25 von 437

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(412)
Mit Volltextzugriff
(365)

Publikationsform

Sprache

Englisch
(437)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations

Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease

Human Mendelian pain disorders: a key to discovery and validation of novel analgesics

Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial

Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease

What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results

Deranged neuronal calcium signaling and Huntington disease

The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma

A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

Personalized gene silencing therapeutics for Huntington disease

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis

The emerging era of pharmacogenomics: current successes, future potential, and challenges

Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

Intestinal ABCA1 directly contributes to HDL biogenesis in vivo

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

Suchergebnisse filtern